(Press-News.org) New research published today in Diabetologia (the journal of the European Association for the Study of Diabetes) indicates that consuming greater quantities of dietary fibre reduces the risk of developing type 2 diabetes.
Over 360 million people worldwide are estimated to be affected by diabetes, and this number is projected to increase to more than 550 million by 2030, with serious consequences for the health and economy of both developed and developing countries. While previous research has found an association between increased dietary fibre intake and a reduced risk of developing type 2 diabetes, most of these data come from the United States, and amounts and sources of fibre intake differ substantially between countries. In this article the authors evaluated the associations between total fibre as well as fibre from cereal, fruit, and vegetable sources, and new-onset type 2 diabetes in a large European cohort across eight countries, in the EPIC-InterAct Study. They also conducted a meta-analysis where they combined the data from this study with those from 18 other independent studies from across the globe.
Dagfinn Aune, a PhD student affiliated with the Norwegian University of Science and Technology and Imperial College London, analysed data from EPIC-InterAct together with colleagues. The EPIC-InterAct study is the world's largest study of new-onset type 2 diabetes, and is coordinated by the MRC Epidemiology Unit at Cambridge University. EPIC-InterAct includes 12,403 verified incident cases of type 2 diabetes, and, for comparison, a sub-cohort of 16,835 individuals deemed representative of the total cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC) study including some 350,000 participants.
The authors divided the study participants into four equally sized groups from lowest to highest fibre intake, and assessed their risk of developing type 2 diabetes over an average of 11 years' follow-up.
They found that participants with the highest total fibre intake (more than 26 g/day) had an 18% lower risk of developing diabetes compared to those with the lowest total fibre intake (less than 19g/day), after adjusting for the effect of other lifestyle and dietary factors. When the results were adjusted for body mass index (BMI) as a marker of obesity, higher total fibre intake was found to be no longer associated with a lower risk of developing diabetes, suggesting that the beneficial association with fibre intake may be mediated at least in part by BMI. In other words, dietary fibre may help people maintain a healthy weight, which in turn reduces the chances of developing type 2 diabetes.
When the authors evaluated the different fibre sources, they found that cereal fibre had the strongest inverse association: those with the highest levels of cereal and vegetable fibre consumption had a 19% and 16% lower risk of developing diabetes respectively, compared with those with the lowest consumption of these types of fibre. Again, these associations disappeared when the results were adjusted for BMI. By contrast, fruit fibre was not associated with a reduction in diabetes risk. Cereals accounted for 38% of the total fibre intake, and were the main source of fibre in all the countries involved in the study (with the exception of France where vegetables were the main source).
The authors also undertook a meta-analysis, where they pooled the data from this EPIC-InterAct study with those from 18 other independent studies (eight in the United States, four in Europe, three in Australia, and three in Asia). The meta-analysis included over 41,000 new-onset cases of type 2 diabetes and found that the risk of diabetes fell by 9% for each 10g/day increase in total fibre intake, and by 25% for each 10g/day increase in cereal fibre intake. They did not find a statistically significant relationship between increasing either fruit or vegetable fibre and reducing diabetes risk.
Dagfinn Aune said: "Taken together, our results indicate that individuals with diets rich in fibre, in particular cereal fibre, may be at lower risk of type 2 diabetes. We are not certain why this might be, but potential mechanisms could include feeling physically full for longer, prolonged release of hormonal signals, slowed down nutrient absorption, or altered fermentation in the large intestine. All these mechanisms could lead to a lower BMI and reduced risk of developing type 2 diabetes. As well as helping keep weight down, dietary fibre may also affect diabetes risk by other mechanisms -- for instance improving control of blood sugar and decreasing insulin peaks after meals, and increasing the body's sensitivity to insulin."
Professor Nick Wareham, senior author on the paper and Director of the MRC Epidemiology Unit, University of Cambridge, added: "This work adds to the growing evidence of the health benefits of diets rich in fibre, in particular cereal fibre. Public health measures globally to increase fibre consumption are therefore likely to play an important part in halting the epidemics of obesity and of type 2 diabetes."
INFORMATION:
Professor Teppo Järvinen and colleagues say drug treatment "can achieve at best a marginal reduction in hip fractures at the cost of unnecessary harms and considerable waste of monetary resources." The article is part of The BMJ's Too Much Medicine campaign -- to highlight the threat to human health and the waste of resources caused by unnecessary care.
Worldwide, about 1.5 million hip fractures occur each year. They impose an enormous burden on healthcare resources and, with a growing elderly population, their incidence is predicted to rise.
Before the late ...
The results show that pills containing one of the newer types of progestogen hormone (drospirenone, desogestrel, gestodene, and cyproterone) are associated with an increased risk of VTE than pills containing older progestogens (levonorgestrel and norethisterone).
The researchers, based at the University of Nottingham, say this is "an important clarifying study" that "has sufficient power to provide reliable comparative findings for different formulations of combined oral contraceptives."
About 9% of women of reproductive age worldwide use oral contraceptives, rising ...
James Rucker, a psychiatrist and honorary lecturer at the Institute of Psychiatry, Psychology and Neuroscience, King's College London, describes how these drugs "were extensively used and researched in clinical psychiatry" before their prohibition in 1967.
He explains that many trials of psychedelics published before prohibition, in the 1950s and 1960s, suggested "beneficial change in many psychiatric disorders".
However, research ended after 1967. In the UK psychedelic drugs were legally classified as schedule 1 class A drugs - that is, as having "no accepted medical ...
PHILADELPHIA -- HDL is the 'good cholesterol' that helps remove fat from artery walls, reversing the process that leads to heart disease. Yet recent drug trials and genetic studies suggest that simply pushing HDL levels higher doesn't necessarily reduce the risk of heart disease. Now, a team led by scientists from the Perelman School of Medicine at the University of Pennsylvania has shown in a large, forward-looking epidemiological study that a person's HDL function -- the efficiency of HDL molecules at removing cholesterol -- may be a better measure of coronary heart disease ...
A risk gene for dyslexia is associated with impairments in visual motion detection, according to a study published May 27 in The Journal of Neuroscience. Mutations in the gene DCDC2 have previously been associated with dyslexia, and this study found that dyslexics with an altered copy of the gene are unable to detect certain types of visual motion.
The researchers used a series of visual tests to compare typical readers with two groups of dyslexics -- one with and one without a specific deletion in the DCDC2 gene.
The subjects were presented with images of patterned ...
Oklahoma Medical Research Foundation scientists have pinpointed a cell that begins the process of scarring in fatty tissue. The findings cast new light on a biological process that occurs with obesity and can lead to diabetes.
"Scarring can be an important part of the healing process when a person suffers an injury," said OMRF's Lorin Olson, Ph.D., who led the research. "But excessive scarring, or fibrosis, can contribute to many dangerous health conditions."
The new research appears in the June 1 issue of the journal Genes & Development.
Using experimental models, ...
One of the major challenges of cocaine addiction is the high rate of relapse after periods of withdrawal and abstinence. But new research reveals that changes in our DNA during drug withdrawal may offer promising ways of developing more effective treatments for addiction.
Withdrawal from drug use results in reprogramming of the genes in the brain that lead to addictive personality, say researchers from McGill University and Bar Ilan University in a new study published in the Journal of Neuroscience.
"We inherit our genes from our parents and these genes remain fixed ...
New York, NY--May 25, 2015--Under the direction of Latha Venkataraman, associate professor of applied physics at Columbia Engineering, researchers have designed a new technique to create a single-molecule diode, and, in doing so, they have developed molecular diodes that perform 50 times better than all prior designs. Venkataraman's group is the first to develop a single-molecule diode that may have real-world technological applications for nanoscale devices. Their paper, "Single-Molecule Diodes with High On-Off Ratios through Environmental Control," is published May 25 ...
DALLAS, May 26, 2015 -- Drinking two or more alcoholic beverages daily may damage the heart of elderly people, according to research in the American Heart Association journal Circulation: Cardiovascular Imaging.
The study correlated weekly alcohol consumption among 4,466 people -- average age 76 -- to the size, structure and motion of various parts of the heart.
Researchers found:
The more people drank, the greater the subtle changes to the heart's structure and function.
Among men, drinking more than 14 alcoholic beverages weekly (heavy drinking) was linked with ...
DALLAS, May 26, 2015 - A vaccine may one day help lower blood pressure for up to six months, according to new research in the American Heart Association's journal Hypertension.
The study in rats may eventually provide a novel alternative to treat high blood pressure in people, who would not need to take a pill everyday.
"The potential of a vaccine for hypertension offers an innovative treatment that could be very effective for the control of non-compliance which is one of the major problems in the management of hypertensive patients," said Hironori Nakagami M.D., ...
